This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ortho Clinical Diagnostics Holdings plc(NasdaqGS:OCDX) dropped from S&P Global BMI Index CI
Ortho Clinical Diagnostics Holdings plc(NasdaqGS:OCDX) dropped from S&P Healthcare Equipment Select Industry Index CI
Ortho Clinical Diagnostics Holdings plc(NasdaqGS:OCDX) dropped from S&P TMI Index CI
Ortho Clinical Diagnostics Holdings plc Terminates Credit Agreement CI
Quidel Corporation completed the acquisition of Ortho Clinical Diagnostics Holdings plc. CI
Quidel, Ortho Clinical Expect Pending Transaction to Close on Friday MT
Ortho Clinical Diagnostics Holdings plc(NasdaqGS:OCDX) dropped from NASDAQ Composite Index CI
Quidel's Shareholders Approve Ortho Clinical Diagnostics Holdings Acquisition Deal MT
Ortho Clinical Diagnostics Holdings plc Reports Earnings Results for the First Quarter Ended April 03, 2022 CI
Transcript : Ortho Clinical Diagnostics Holdings plc, Q1 2022 Earnings Call, May 04, 2022
Insider Sell: Ortho Clinical Diagnostics Holdings MT
Morgan Stanley Downgrades Ortho Clinical Diagnostics to Equal Weight From Overweight, Lowers PT to $16.90 From $26 MT
Evercore ISI Upgrades Ortho Clinical Diagnostics Holdings to Outperform From In-Line; Price Target is $21 MT
Transcript : Ortho Clinical Diagnostics Holdings plc, Q4 2021 Earnings Call, Feb 16, 2022
Ortho Clinical Diagnostics Holdings plc Reports Earnings Results for the Full Year Ended January 02, 2022 CI
Ortho Clinical Diagnostics Holdings plc Reports Earnings Results for the Fourth Quarter Ended January 02, 2022 CI
Ortho Clinical Diagnostics Seeks UK Court Approval of Shareholder Vote on Acquisition by Quidel MT
Transcript : Ortho Clinical Diagnostics Holdings plc Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 09:00 AM
Insider Sell: Ortho Clinical Diagnostics Holdings MT
Insider Sell: Ortho Clinical Diagnostics Holdings MT
Ortho Clinical Diagnostics Holdings Reports Preliminary Q4 Revenue Range in Line With Estimates MT
Ortho Clinical Diagnostics Holdings plc Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Fiscal Year Ended January 2, 2022 CI
Ortho Clinical Diagnostics Holdings plc Provides Earnings Guidance for the Fourth Quarter Ended January 2, 2022 CI
HC Wainwright Downgrades Ortho Clinical Diagnostics to Neutral From Buy Amid Deal to Be Bought by Quidel MT
Barclays Cuts Ortho Clinical Diagnostics Holdings to Equalweight From Overweight, Price Target to $25 From $29 MT
Chart Ortho Clinical Diagnostics Holdings plc
More charts
Ortho Clinical Diagnostics Holdings PLC is an in vitro diagnostics (IVD) diagnostic company. The Company provides laboratory testing and blood-typing solutions to the clinical laboratory and transfusion medicine communities. The Company provides customized solutions for clinical outcomes, lab performance and staffing challenges. The Company operates through two lines of business such as Clinical Laboratories and Transfusion Medicine. Its Clinical Laboratories business focuses on clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across therapeutic areas. The Transfusion Medicine business is focused on immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions. Its Donor Screening business is focused on instruments and tests used for blood and plasma screening for infectious diseases for customers, which include some of the donor testing institutions.
More about the company
  1. Stock Market
  2. Equities
  3. OCDX Stock
  4. News Ortho Clinical Diagnostics Holdings plc
  5. Health Care Stocks Posting Modest Advance This Afternoon